Cite
HARVARD Citation
Jin, A. et al. (2022). CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis. Clinical and translational medicine. 12 (4), p. n/a. [Online].